AGNAEGON LTD.

NYSE aegon.com


$ 193.09 $ 0.03 (0.02 %)    

Friday, 08-May-2020 15:59:58 EDT
QQQ $ 439.55 $ -0.26 (-0.06 %)
DIA $ 390.50 $ 1.74 (0.45 %)
SPY $ 517.10 $ 0.05 (0.01 %)
TLT $ 90.18 $ -0.55 (-0.61 %)
GLD $ 213.58 $ -0.63 (-0.29 %)
$ 193.02
$ 193.05 x 100
$ 194.80 x 200
-- - --
$ 112.94 - $ 200.67
12,442,653
na
14.24B
$ 0.69
$ 113.93
TBD
na
na ($ 0.04)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

By Anita Dushyanth, PhD NASDAQ:INMB | NASDAQ:NTRP | TSX:PMN.TO Rethinking the approach to treat Alzheimer's disease

 fda-issues-warning-letter-to-allergan-for-failing-to-comply-with-requirements--under-2-separate-premarket-approval-orders

-Reuters

 the-daily-biotech-pulse-fda-approves-novartis-lung-cancer-drug-2-way-contest-emerging-for-tetraphase-pharma-dexcom-to-join-sp-500

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks hitti...

 the-daily-biotech-pulse-fda-nod-for-astrazeneca-abbvie-allergan-deal-clears-antitrust-hurdle

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peak (Biotech Stocks Hittin...

Core News & Articles

-Reuters

Core News & Articles

Upgrades

 suntrust-robinson-humphrey-downgrades-allergan-to-hold-raises-price-target-to-193

SunTrust Robinson Humphrey analyst Gregg Gilbert downgrades Allergan (NYSE:AGN) from Buy to Hold and raises the price target...

 abbvie-analyst-upgrades-stock-to-outperform-looks-forward-to-2021

AbbVie Inc (NYSE: ABBV) shares already discount much of the risk emanating from the COVID-19 crisis, according to an analyst at...

 cfra-downgrades-allergan-to-hold
CFRA Downgrades Allergan to Hold
03/25/2020 16:43:53

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION